Winona’s patch and combination body cream raise different product questions. The prescription record needs to resolve ingredient identity, approval status and refill timing before their prices can be compared.
A person researching Winona can encounter a transdermal estradiol patch, a body cream containing several hormones and general descriptions of bioidentical treatment in the same browsing session. Those records do not describe one interchangeable medicine. This assessment starts by separating the products, then follows the information needed to connect an online proposal with the item eventually dispensed.
We reviewed Winona’s official FAQ and product pages on September 28, 2026. No intake, prescription or parcel was tested. Winona has an actual clinician-led menopause service, but its public catalog cannot establish an individual’s suitability or identify the exact patch manufacturer or compounded formula a future prescription would name.
The estrogen patch page identifies estradiol and describes delivery through the skin. It also calls the product FDA approved. That is a provider statement about this offering, rather than evidence that every Winona hormone preparation has the same approval status. The public description leaves the actual prescription and dispensing label essential.
Useful details would include the complete medicine name, manufacturer where applicable, prescribed strength and quantity, and the responsible pharmacy. A photograph or description of a patch shape cannot supply those fields reliably. The patch, tablet and gel questions explain why naming the route is only one part of recognizing a medicine.
Winona’s combination body-cream record lists estradiol, estriol and progesterone. It therefore should not be summarized as simply the cream version of its estradiol patch. Adding a different estrogen and another hormone changes the product description before any clinical comparison is attempted.
The page makes claims about convenience and uterine protection. This review does not establish that the compounded cream provides an adequate protective regimen for an individual. That question belongs with the prescribing professional. The Joi assessment examines another catalog where a form name alone leaves the complete prescription uncertain; it is a comparison of documentation, not equivalent therapies.
The Winona FAQ contains broad wording describing its hormones as compounded, then separately identifies estrogen tablets, progesterone capsules and patches as FDA approved while acknowledging that compounded creams are not. The narrower product distinction should remain visible instead of being flattened into a single brand-wide approval claim.
FDA’s compounding explanation states that compounded drugs are not FDA approved. A named ingredient or licensed pharmacy does not confer finished-product approval. Readers can ask which exact preparation the clinician is proposing and where its labeling comes from. This review neither verifies a pharmacy inspection nor treats plant-derived or bioidentical wording as proof of comparative safety.
Winona describes medical-intake review by a physician licensed in the patient’s state. Its FAQ limits the hormone program to ages 35–59 and lists participating states and Puerto Rico. These are platform boundaries, not a general medical rule about who should receive estradiol. A listed jurisdiction also does not prove acceptance of a particular application.
Physician communication is by portal messaging rather than scheduled phone or video calls. The FAQ describes responses commonly taking 24–48 hours and sometimes longer. The Gennev review contrasts a scheduled video consultation. Someone wanting to discuss a complicated label can compare how the question reaches a clinician, without assuming either communication format predicts treatment quality.
The patch page displays a starting price of $149 per month, while the combination cream starts at $89 per month. These figures do not establish the same ingredients, prescription quantity or complete treatment cost. Another prescribed item could change the total, and a starting price does not identify the selected strength or shipment.
Winona says it does not bill insurance directly. Its HSA/FSA payment and receipt options should not be interpreted as guaranteed reimbursement. The label and pharmacy record guide provides a useful place to separate the medicine’s identity from the charge attached to it. A price comparison is incomplete until both are clear.
The FAQ describes automatic processing every 28 days for a stated 30-day supply and every 84 days for a stated 90-day supply. Those are the provider’s billing and refill descriptions; this article supplies no application schedule. The same FAQ makes an exception for vaginal estrogen cream and sildenafil cream, whose refills must be requested rather than assumed automatic.
An order has a 24-hour cancellation window before it becomes noncancellable and nonrefundable under the published terms. Cancelling future subscription activity is therefore different from reversing an order already in processing. Standard shipping is described as free, while faster methods can cost extra. Delivery estimates were not tested.
A useful record would show what was discussed, what was prescribed and what the pharmacy actually supplied. If those descriptions differ, the prescriber and pharmacist are the appropriate people to reconcile them. The medication-list guide helps keep existing products visible during that conversation without making a substitution or compatibility decision.
Winona’s public records make a patch-versus-blend distinction possible, but they do not complete that reconciliation for a patient. This review offers no instruction to switch forms, change an amount or combine products. Its conclusion is documentary: identify the exact preparation before reading a broad hormone claim, a monthly price or an automatic refill as the whole treatment proposal.
Follow the source
Provider pages describe services. Medical and regulatory sources supply clinical context. None of these references substitutes for a personal assessment.